NCT04445051View on ClinicalTrials.gov

Investigation of New Intermittent Catheters in Healthy Volunteers

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

September 1, 2020

Study Completion Date

September 1, 2020

Conditions
Retention, Urinary
Interventions
DEVICE

SpeediCath® Standard male or female

Intermittent catheterization through the urethra draining the bladder, using SpeediCath® Standard male or female.

DEVICE

New intermittent Variant 1 catheter for male or female

Intermittent catheterization through the urethra draining the bladder, using the new Variant 1 for male or female.

DEVICE

New intermittent Variant 2 catheter for male or female

Intermittent catheterization through the urethra draining the bladder, using the new Variant 2 for male or female.

Trial Locations (1)

2100

Urologisk klinik, Afsnit 2112, Rigshospitalet, Copenhagen

Sponsors

Lead Sponsor

Coloplast A/S
All Listed Sponsors
lead

Coloplast A/S

INDUSTRY